Project ECHO NL: Opioid Use Disorder (Cycle 1) Microdosing as an Induction Approach

At the conclusion of this activity, participants will be able to:

• Explain the pharmacologic principles which underlie buprenorphine microdosing strategies.
• Differentiate between microdosing and other approaches to opioid agonist treatment (OAT) induction.
• Describe clinical scenarios where microdosing on to buprenorphine may be appropriate.
• List the steps required to initiate buprenorphine/naloxone for opioid use disorder when microdosing.

Speaker:

Dr. Ken Lee, MD MCFP (Addiction Medicine)
London RAAM Clinic
CMHA Mental Health & Addictions Crisis Centre
Operational Stress Injury Clinic (St. Joseph’s Health Care London)

Direct questions about Project ECHO NL: Opioid Use Disorder to:
Kate Lambert
Knowledge Exchange Facilitator
Provincial Opioid Dependence Treatment Centre of Excellence
Eastern Health

Kate.Lambert@easternhealth.ca

This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the Newfoundland and Labrador Chapter for up to 11 Mainpro+® credits.

Project ECHO NL: Opioid Use Disorder is funded through the Provincial Opioid Dependence Treatment Centre of Excellence (Eastern Health).